Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in Epidemiol Infect

Retrieve available abstracts of 269 articles:
HTML format

Single Articles

    November 2022
  1. BHUIYAN MS, Brintz BJ, Whitcombe AL, Markmann AJ, et al
    Combining antibody markers for serosurveillance of SARS-CoV-2 to estimate seroprevalence and time-since-infection - CORRIGENDUM.
    Epidemiol Infect. 2022;150:e188.

  2. PANDEY BD, Ngwe Tun MM, Pandey K, Dumre SP, et al
    Has COVID-19 suppressed dengue transmission in Nepal?
    Epidemiol Infect. 2022;150:e196.
    PubMed     Abstract available

  3. BEEBEEJAUN K, Pebody R, Ciobanu S, Pukkila J, et al
    UEFA Euro 2020: lessons from the first multi-city international mass gathering during the COVID-19 pandemic.
    Epidemiol Infect. 2022;150:e182.
    PubMed     Abstract available

  4. HEIJMINK L, Tonis J, Gilhuis N, Gerkema M, et al
    Epidemiological evaluation of mass testing in a small municipality in the Netherlands during the SARS-CoV-2 epidemic.
    Epidemiol Infect. 2022;150:e193.
    PubMed     Abstract available

  5. MIYAMA T, Jung SM, Nishiura H
    Decrease in overdispersed secondary transmission of COVID-19 over time in Japan.
    Epidemiol Infect. 2022;150:e197.
    PubMed     Abstract available

  6. MCGRATH J, McAloon CG, More SJ, Garrett S, et al
    Risk factors for SARS-CoV-2 infection in healthcare workers following an identified nosocomial COVID-19 exposure during waves 1-3 of the pandemic in Ireland.
    Epidemiol Infect. 2022;150:e186.
    PubMed     Abstract available

  7. LEE YH, Choe YJ, Lee H, Choi EH, et al
    Spatial distribution of SARS-CoV-2 infection in schools, South Korea.
    Epidemiol Infect. 2022;150:e194.
    PubMed     Abstract available

  8. LE GLASS E, Raoult D, Dubourg G
    Snapshot of COVID-19 superinfections in Marseille hospitals: where are the common pathogens?
    Epidemiol Infect. 2022;150:e195.
    PubMed     Abstract available

    Underestimation of the number of COVID-19 cases, an epidemiological threat.
    Epidemiol Infect. 2022;150:e191.

  10. LIM WW, Cowling BJ, Nakafero G, Feng S, et al
    The impact of repeated vaccination on relative influenza vaccine effectiveness among vaccinated adults in the United Kingdom.
    Epidemiol Infect. 2022 Nov 4:1-30. doi: 10.1017/S0950268822001753.

  11. TSUZUKI S, Akiyama T, Matsunaga N, Ohmagari N, et al
    Association between physical activity status and severity of COVID-19 in older adults.
    Epidemiol Infect. 2022;150:e189.
    PubMed     Abstract available

  12. EBERHARDT AT, Simoncini M, Pina C, Galoppo G, et al
    Preceding anti-spike IgG levels predicted risk and severity of COVID-19 during the Omicron-dominant wave in Santa Fe city, Argentina.
    Epidemiol Infect. 2022;150:e187.
    PubMed     Abstract available

    October 2022
  13. GOLDSTEIN E, Fireman BH, Klein NP, Lipsitch M, et al
    Prescribing for different antibiotic classes across age groups in the Kaiser Permanente Northern California population in association with influenza incidence, 2010-2018.
    Epidemiol Infect. 2022 Oct 26:1-30. doi: 10.1017/S0950268822001662.

  14. FILIPPATOS F, Tatsi EB, Dellis C, Koukou DM, et al
    SARS-CoV-2 seroepidemiology in paediatric population during Delta and Omicron predominance.
    Epidemiol Infect. 2022;150:e177.
    PubMed     Abstract available

  15. MAMISHI S, Olfat M, Pourakbari B, Eshaghi H, et al
    Multisystem inflammatory syndrome associated with SARS-CoV-2 infection in children: update and new insights from the second report of an Iranian referral hospital.
    Epidemiol Infect. 2022;150:e179.
    PubMed     Abstract available

  16. WRIGHT E, Pollard G, Robertson H, Anuradha S, et al
    Household transmission of the Delta COVID-19 variant in Queensland, Australia: a case series.
    Epidemiol Infect. 2022;150:e173.
    PubMed     Abstract available

    September 2022
  17. TAN J, Ge Y, Martinez L, Sun J, et al
    Transmission roles of symptomatic and asymptomatic COVID-19 cases: a modelling study.
    Epidemiol Infect. 2022;150:e171.
    PubMed     Abstract available

  18. ZHOU N, Dai H, Zha W, Lv Y, et al
    The impact of meteorological factors and PM2.5 on COVID-19 transmission - CORRIGENDUM.
    Epidemiol Infect. 2022;150:e164.

  19. HAN H, Blackburn AM, Jeftic A, Tran TP, et al
    Validity testing of the conspiratorial thinking and anti-expert sentiment scales during the COVID-19 pandemic across 24 languages from a large-scale global dataset.
    Epidemiol Infect. 2022;150:e167.
    PubMed     Abstract available

  20. MAGAZZINO C, Mele M, Coccia M
    A machine learning algorithm to analyse the effects of vaccination on COVID-19 mortality.
    Epidemiol Infect. 2022;150:e168.
    PubMed     Abstract available

    August 2022
  21. CHEN CWS, So MKP, Liu FC
    Assessing government policies' impact on the COVID-19 pandemic and elderly deaths in East Asia.
    Epidemiol Infect. 2022;150:e161.
    PubMed     Abstract available

  22. EKROTH AKE, Patrzylas P, Turner C, Hughes GJ, et al
    Comparative symptomatology of infection with SARS-CoV-2 variants Omicron (B.1.1.529) and Delta (B.1.617.2) from routine contact tracing data in England.
    Epidemiol Infect. 2022;150:e162.
    PubMed     Abstract available

  23. BAYS D, Bennett E, Finnie T
    What effect might border screening have on preventing importation of COVID-19 compared with other infections?: considering the additional effect of post-arrival isolation.
    Epidemiol Infect. 2022;150:e159.
    PubMed     Abstract available

  24. PAGEN DME, Brinkhues S, Dukers-Muijrers NHTM, den Heijer CDJ, et al
    Sex and age differences in the proportion of experienced symptoms by SARS-CoV-2 serostatus in a community-based cross-sectional study.
    Epidemiol Infect. 2022;150:e157.
    PubMed     Abstract available

  25. BUCHHOLZ U, An der Heiden M
    Serial interval in households infected with SARS-CoV-2 variant B.1.1.529 (Omicron) are even shorter compared to Delta.
    Epidemiol Infect. 2022 Aug 5:1-5. doi: 10.1017/S0950268822001248.

    July 2022
  26. NIELSEN RT, Dalby T, Emborg HD, Larsen AR, et al
    COVID-19 preventive measures coincided with a marked decline in other infectious diseases in Denmark, spring 2020.
    Epidemiol Infect. 2022;150:e138.
    PubMed     Abstract available

  27. AL-SHEHARI WA, Yin YA, Wang X, Wang Y, et al
    Prevalence and surveillance of tuberculosis in Yemen from 2006 to 2018.
    Epidemiol Infect. 2022;150:e146.
    PubMed     Abstract available

    Spatial growth rate of emerging SARS-CoV-2 lineages in England, September 2020-December 2021.
    Epidemiol Infect. 2022;150:e145.
    PubMed     Abstract available

  29. PRICE O, Birrell FA, Mifsud EJ, Sullivan SG, et al
    Epidemiology of repeat influenza infection in Queensland, Australia, 2005-2017.
    Epidemiol Infect. 2022 Jul 18:1-19. doi: 10.1017/S0950268822001157.

  30. SILVA MJA, Rodrigues YC, Lima KVB, Lima LNGC, et al
    Innate immunity to SARS-CoV-2 infection: a review.
    Epidemiol Infect. 2022;150:e142.
    PubMed     Abstract available

  31. IMPOUMA B, Mboussou F, Farham B, Makubalo L, et al
    COVID-19 vaccination rollout in the World Health Organization African region: status at end June 2022 and way forward.
    Epidemiol Infect. 2022;150:e143.
    PubMed     Abstract available

  32. JANNUZZI P, Panza GA
    Author response to: Letter to Editor in Response to the association between contact with children and the clinical course of COVID-19.
    Epidemiol Infect. 2022;150:e139.

  33. LOSS J, Wurm J, Varnaccia G, Schienkiewitz A, et al
    Transmission of SARS-CoV-2 among children and staff in German daycare centres.
    Epidemiol Infect. 2022;150:e141.
    PubMed     Abstract available

  34. AUSTHOF E, Bell ML, Riddle MS, Catalfamo C, et al
    Persisting gastrointestinal symptoms and post-infectious irritable bowel syndrome following SARS-CoV-2 infection: results from the Arizona CoVHORT.
    Epidemiol Infect. 2022 Jul 8:1-22. doi: 10.1017/S0950268822001200.

  35. SOYEMI E, Soyemi K
    Response to the association between contact with children and the clinical course of COVID-19.
    Epidemiol Infect. 2022;150:e140.

    June 2022
  36. DE MARCO VERISSIMO C, Lopez Corrales J, Dorey AL, Cwiklinski K, et al
    Production of a functionally active recombinant SARS-CoV-2 (COVID-19) 3C-like protease and a soluble inactive 3C-like protease-RBD chimeric in a prokaryotic expression system.
    Epidemiol Infect. 2022;150:e128.
    PubMed     Abstract available

  37. JUDSON SD, Torimiro J, Pigott DM, Maima A, et al
    COVID-19 data reporting systems in Africa reveal insights for future pandemics.
    Epidemiol Infect. 2022;150:e119.
    PubMed     Abstract available

  38. DEN BOOGERT EM, de Lange MMA, Wielders CCH, Rietveld A, et al
    Incidence and severity of SARS-CoV-2 infection in former Q fever patients as compared to the Dutch population, 2020-2021.
    Epidemiol Infect. 2022;150:e116.
    PubMed     Abstract available

    May 2022
  39. ADAMSON JP, Smith C, Pacchiarini N, Connor TR, et al
    A large outbreak of COVID-19 in a UK prison, October 2020 to April 2021.
    Epidemiol Infect. 2022;150:e134.
    PubMed     Abstract available

  40. RAY I, Hasan MM, Shah PA, Sahito AM, et al
    HIV epidemic amidst COVID-19 pandemic in India: a conundrum for the country's healthcare system.
    Epidemiol Infect. 2022;150:e112.
    PubMed     Abstract available

  41. XU X, Zhang K, Ma H, Shen X, et al
    Differences in service and antibiotics use following symptomatic respiratory tract infections between 2016 and 2021 in rural Anhui, China.
    Epidemiol Infect. 2022;150:e117.
    PubMed     Abstract available

  42. LACY J, Mensah A, Simmons R, Andrews N, et al
    Protective effect of a first SARS-CoV-2 infection from reinfection: a matched retrospective cohort study using PCR testing data in England.
    Epidemiol Infect. 2022;150:e109.
    PubMed     Abstract available

  43. PARROTT JC, Annibale AM, Osahan S, Alroy K, et al
    Prevalence of SARS-CoV-2 antibodies during phased access to vaccination: results from a population-based survey in New York City, September 2020-March 2021.
    Epidemiol Infect. 2022;150:e105.
    PubMed     Abstract available

  44. EDELMAN NL, Simon P, Cassell JA, Kiss IZ, et al
    Network analysis of England's single parent household COVID-19 control policy impact: a proof-of-concept study.
    Epidemiol Infect. 2022;150:e104.
    PubMed     Abstract available

  45. LONG H, Li J, Li R, Zhang H, et al
    Plasma glucose levels and diabetes are independent predictors for mortality in patients with COVID-19.
    Epidemiol Infect. 2022;150:e106.
    PubMed     Abstract available

  46. SHINGLETON J, Finnie T, Gent N, Bennett E, et al
    Assessing the role of imported cases on the establishment of SARS-CoV-2 Delta variant of concern in Bolton, UK.
    Epidemiol Infect. 2022;150:e100.
    PubMed     Abstract available

  47. HIIRONEN I, Saavedra-Campos M, Panitz J, Ma T, et al
    Workplace exposures associated with COVID-19: evidence from a case-control study with multiple sampling periods in England, August-October 2020.
    Epidemiol Infect. 2022;150:e99.
    PubMed     Abstract available

  48. THOMAS DR, Fina LH, Adamson JP, Sawyer C, et al
    Social, demographic and behavioural determinants of SARS-CoV-2 infection: a case-control study carried out during mass community testing of asymptomatic individuals in South Wales, December 2020.
    Epidemiol Infect. 2022;150:e115.
    PubMed     Abstract available

  49. POKUTNAYA D, Loiacono MM, Booth H, Williams R, et al
    The impact of clinical risk conditions on influenza and pneumonia diagnoses in England: a nationally-representative retrospective cohort study, 2010-2019.
    Epidemiol Infect. 2022 May 6:1-24. doi: 10.1017/S0950268822000838.

    April 2022
  50. WONG JY, Cheung CM, Bond HS, Cheung JK, et al
    Estimating excess septicaemia mortality and hospitalisation burden associated with influenza in Hong Kong, 1998 to 2019.
    Epidemiol Infect. 2022;150:e101.
    PubMed     Abstract available

  51. FABRICIUS G, Borzi RA, Caminos J, Grigera TS, et al
    Immunity acquired by a minority active fraction of the population could explain COVID-19 spread in Greater Buenos Aires (June-November 2020).
    Epidemiol Infect. 2022;150:e84.
    PubMed     Abstract available

  52. RICCARDO F, Frisicale EM, Guzzetta G, Ferraro F, et al
    Winning during a pandemic: epidemiology of SARS-CoV-2 during EURO2020 in Italy.
    Epidemiol Infect. 2022;150:e166.
    PubMed     Abstract available

    March 2022
  53. SCHULMAN A, Bhanot G
    Using postal change-of-address data to predict second waves in infections near pandemic epicentres.
    Epidemiol Infect. 2022;150:e120.
    PubMed     Abstract available

  54. BENNEDBAEK M, Button MSF, Nielsen LB, Bybjerg-Grauholm J, et al
    Increased transmission of SARS-CoV-2 in Denmark during UEFA European championships.
    Epidemiol Infect. 2022;150:e123.
    PubMed     Abstract available

  55. SARVIKIVI E, Salminen M, Savolainen-Kopra C, Ikonen N, et al
    COVID-19 cases in spectators returning to Finland from UEFA Euro 2020 matches in Saint Petersburg.
    Epidemiol Infect. 2022;150:e121.
    PubMed     Abstract available

  56. DASH P, Mansingh A, Nayak SR, Sahoo D, et al
    Infection, cases due to SARS-CoV-2 in rural areas during early COVID-19 vaccination: findings from serosurvey study in a rural cohort of eastern India.
    Epidemiol Infect. 2022;150:e58.
    PubMed     Abstract available

  57. HUANG Z, Guo H, Lim HY, Chow A, et al
    Determinants of the acceptance and adoption of a digital contact tracing tool during the COVID-19 pandemic in Singapore.
    Epidemiol Infect. 2022;150:e54.
    PubMed     Abstract available

    February 2022
  58. GOLDSTEIN E, Fireman BH, Klein NP, Lipsitch M, et al
    Antibiotic prescribing across age groups in the Kaiser Permanente Northern California population in association with different diagnoses, and with influenza incidence, 2010-2018.
    Epidemiol Infect. 2022;150:e85.
    PubMed     Abstract available

  59. AWAN HA, Sahito AM, Sukaina M, Khatri G, et al
    Tuberculosis amidst COVID-19 in Pakistan: a massive threat of overlapping crises for the fragile healthcare systems.
    Epidemiol Infect. 2022;150:e41.
    PubMed     Abstract available

  60. PECKEU-ABBOUD L, van Kleef E, Smekens T, Latour K, et al
    Factors influencing SARS-CoV-2 infection rate in Belgian nursing home residents during the first wave of COVID-19 pandemic.
    Epidemiol Infect. 2022;150:e72.
    PubMed     Abstract available

  61. YUN KW, Kim YK, Song ES, An HY, et al
    Outbreak of COVID-19 among children and young adults in a cancer centre daycare unit.
    Epidemiol Infect. 2022;150:e40.
    PubMed     Abstract available

  62. CORDIOLI M, Mirandola M, Gios L, Gaspari S, et al
    COVID-19 seroprevalence amongst healthcare workers: potential biases in estimating infection prevalence.
    Epidemiol Infect. 2022;150:e48.
    PubMed     Abstract available

  63. HEINZINGER S, Eberle U, Angermeier H, Flechsler J, et al
    Reciprocal circulation pattern of SARS-CoV-2 and influenza viruses during the influenza seasons 2019/2020 and 2020/2021 in the Bavarian Influenza Sentinel (Germany) - CORRIGENDUM.
    Epidemiol Infect. 2022;150:e24.

  64. BROOKES SM, Mansfield KL, Reid SM, Coward V, et al
    Incursion of H5N8 High Pathogenicity Avian Influenza Virus (HPAIV) into Gamebirds in England.
    Epidemiol Infect. 2022 Feb 10:1-36. doi: 10.1017/S0950268821002740.

  65. POMEROY MA, Hoover ER, Dumas BL, Kennedy KS, et al
    Decisions to attend holiday gatherings during COVID-19 and engagement in key prevention strategies: United States, January 2021.
    Epidemiol Infect. 2022;150:e32.
    PubMed     Abstract available

  66. SEVINC SA, Metin S, Basi NB, Ling J, et al
    Effectiveness of inactivated SARS-CoV-2 vaccine (CoronaVac) on intensive care unit survival.
    Epidemiol Infect. 2022;150:e35.
    PubMed     Abstract available

  67. HAN H
    Trust in the scientific research community predicts intent to comply with COVID-19 prevention measures: An analysis of a large-scale international survey dataset.
    Epidemiol Infect. 2022;150:e36.
    PubMed     Abstract available

  68. NA'AMNIH W, Kassem E, Tannous S, Kagan V, et al
    Incidence and risk factors of hospitalisations for respiratory syncytial virus among children aged less than 2 years.
    Epidemiol Infect. 2022;150:e45.
    PubMed     Abstract available

    January 2022
  69. SMITH JAE, Hopkins S, Turner C, Dack K, et al
    Public health impact of mass sporting and cultural events in a rising COVID-19 prevalence in England.
    Epidemiol Infect. 2022;150:e42.
    PubMed     Abstract available

  70. KASSIE A, Handebo S, Adugna A, Shitu K, et al
    Violence against girls during COVID-19 pandemic and associated factors in Gondar city, North West Ethiopia.
    Epidemiol Infect. 2022;150:e31.
    PubMed     Abstract available

  71. LIU F, Zhao Z, Ma C, Nie X, et al
    Return to normal pre-COVID-19 life is delayed by inequitable vaccine allocation and SARS-CoV-2 variants.
    Epidemiol Infect. 2022;150:e46.
    PubMed     Abstract available

  72. ZHOU N, Dai H, Zha W, Lv Y, et al
    The impact of meteorological factors and PM2.5 on COVID-19 transmission.
    Epidemiol Infect. 2022;150:e38.
    PubMed     Abstract available

  73. SPAHN C, Hipp AM, Richter B, Nusseck M, et al
    Coronavirus vaccination rates in cultural areas in Germany.
    Epidemiol Infect. 2022;150:e34.
    PubMed     Abstract available

  74. DECUIR J, Baggs J, Melgar M, Patel P, et al
    Identification and description of patients with multisystem inflammatory syndrome in adults associated with SARS-CoV-2 infection using the Premier Healthcare Database.
    Epidemiol Infect. 2022;150:e26.
    PubMed     Abstract available

  75. ESKILD A, Morkrid L, Mortensen SB, Leegaard TM, et al
    Prevalence of antibodies against SARS-CoV-2 among pregnant women in Norway during the period December 2019 through December 2020.
    Epidemiol Infect. 2022;150:e28.
    PubMed     Abstract available

  76. LIM C, Nam Y, Oh WS, Ham S, et al
    Characteristics of transmission routes of COVID-19 cluster infections in Gangwon Province, Korea.
    Epidemiol Infect. 2022;150:e19.
    PubMed     Abstract available

  77. BHUIYAN MS, Brintz BJ, Whitcombe AL, Markmann AJ, et al
    Combining antibody markers for serosurveillance of SARS-CoV-2 to estimate seroprevalence and time-since-infection.
    Epidemiol Infect. 2022;150:e20.
    PubMed     Abstract available

  78. CAVANY S, Bivins A, Wu Z, North D, et al
    Inferring SARS-CoV-2 RNA shedding into wastewater relative to the time of infection.
    Epidemiol Infect. 2022;150:e21.
    PubMed     Abstract available

    December 2021
  79. NOAH N, Edelstein M
    African COVID-19 special issue introduction.
    Epidemiol Infect. 2021;149:e257.

  80. SCHOOLING CM, Li M, Au Yeung SL
    Interleukin-18 and COVID-19.
    Epidemiol Infect. 2021;150:e14.
    PubMed     Abstract available

  81. TSUZUKI S, Ohmagari N, Beutels P
    The burden of isolation to the individual: a comparison between isolation for COVID-19 and for other influenza-like illnesses in Japan.
    Epidemiol Infect. 2021;150:e5.
    PubMed     Abstract available

  82. MUGHINI-GRAS L, Chaname Pinedo L, Pijnacker R, van den Beld M, et al
    Impact of the COVID-19 pandemic on human salmonellosis in the Netherlands.
    Epidemiol Infect. 2021;149:e254.
    PubMed     Abstract available

    November 2021
  83. ALJOHANI NI, Mutai K
    Effect of non-pharmacological interventions on the COVID-19 epidemic in Saudi Arabia.
    Epidemiol Infect. 2021;149:e252.
    PubMed     Abstract available

  84. MUNCH PK, Espenhain L, Hansen CH, Muller L, et al
    Societal activities associated with SARS-CoV-2 infection: a case-control study in Denmark, November 2020.
    Epidemiol Infect. 2021;150:e9.
    PubMed     Abstract available

  85. MAGAZZINO C, Mele M, Schneider N
    Assessing a fossil fuels externality with a new neural networks and image optimisation algorithm: the case of atmospheric pollutants as confounders to COVID-19 lethality.
    Epidemiol Infect. 2021;150:e1.
    PubMed     Abstract available

  86. LAI J, Hughes HE, Morbey R, Loveridge P, et al
    Developing a sentinel syndromic surveillance system using school-absenteeism data, example monitoring absences over the 2020 COVID-19 pandemic.
    Epidemiol Infect. 2021;149:e248.
    PubMed     Abstract available

  87. TATSI EB, Filippatos F, Michos A
    SARS-CoV-2 variants and effectiveness of vaccines: a review of current evidence.
    Epidemiol Infect. 2021;149:e237.
    PubMed     Abstract available

  88. BAYS D, Bennett E, Finnie T
    What effect might border screening have on preventing the importation of COVID-19 compared with other infections? A modelling study.
    Epidemiol Infect. 2021;149:e238.
    PubMed     Abstract available

  89. IMPOUMA B, Mboussou F, Shahpar C, Wolfe CM, et al
    Estimating the SARS-CoV2 infections detection rate and cumulative incidence in the World Health Organization African Region 10 months into the pandemic.
    Epidemiol Infect. 2021;149:e264.
    PubMed     Abstract available

  90. IMPOUMA B, Mboussou F, Farham B, Wolfe CM, et al
    The COVID-19 pandemic in the WHO African region: the first year (February 2020 to February 2021).
    Epidemiol Infect. 2021;149:e263.
    PubMed     Abstract available

  91. LI R, Li Q, Liu Y, Shen M, et al
    Modelling the impact of universal influenza vaccines on seasonal influenza with different subtypes.
    Epidemiol Infect. 2021;149:e253.
    PubMed     Abstract available

    October 2021
  92. NICHOLS M, Gollarza L, Palacios A, Stapleton GS, et al
    Salmonella illness outbreaks linked to backyard poultry purchasing during the COVID-19 pandemic: United States, 2020.
    Epidemiol Infect. 2021;149:e234.
    PubMed     Abstract available

  93. JUUTINEN A, Sarvikivi E, Laukkanen-Nevala P, Helve O, et al
    Closing lower secondary schools had no impact on COVID-19 incidence in 13-15-year-olds in Finland.
    Epidemiol Infect. 2021;149:e233.
    PubMed     Abstract available

  94. HEINZINGER S, Eberle U, Angermeier H, Flechsler J, et al
    Reciprocal circulation pattern of SARS-CoV-2 and influenza viruses during the influenza seasons 2019/2020 and 2020/2021 in the Bavarian Influenza Sentinel (Germany).
    Epidemiol Infect. 2021;149:e226.
    PubMed     Abstract available

  95. MANCILLA-GALINDO J, Kammar-Garcia A, Martinez-Esteban A, Meza-Comparan HD, et al
    COVID-19 patients with increasing age experience differential time to initial medical care and severity of symptoms.
    Epidemiol Infect. 2021;149:e230.
    PubMed     Abstract available

  96. GONZALEZ F, Vielot NA, Sciaudone M, Toval-Ruiz C, et al
    Seroepidemiology of SARS-CoV-2 infections in an urban population-based cohort in Leon, Nicaragua.
    Epidemiol Infect. 2021;149:e247.
    PubMed     Abstract available

  97. AEMRO A, Amare NS, Shetie B, Chekol B, et al
    Determinants of COVID-19 vaccine hesitancy among health care workers in Amhara region referral hospitals, Northwest Ethiopia: a cross-sectional study.
    Epidemiol Infect. 2021;149:e225.
    PubMed     Abstract available

  98. SINGH C, Naik BN, Pandey S, Biswas B, et al
    Effectiveness of COVID-19 vaccine in preventing infection and disease severity: a case-control study from an Eastern State of India.
    Epidemiol Infect. 2021;149:e224.
    PubMed     Abstract available

  99. ZHAO X, Shen Z, Sun L, Cheng L, et al
    A network meta-analysis of secondary attack rates of COVID-19 in different contact environments.
    Epidemiol Infect. 2021;149:e219.
    PubMed     Abstract available

    September 2021
  100. KEITA MB, Pierre F, Ndjomou J, Traore B, et al
    The first epidemiological and virological influenza surveillance in the Republic of Guinea revealed the predominance of influenza A/H3N2 and B Victoria viruses.
    Epidemiol Infect. 2021 Sep 28:1-20. doi: 10.1017/S0950268821001965.

  101. SCHOEPS A, Hoffmann D, Tamm C, Vollmer B, et al
    Surveillance of SARS-CoV-2 transmission in educational institutions, August to December 2020, Germany.
    Epidemiol Infect. 2021;149:e213.
    PubMed     Abstract available

  102. CHENG X, Li Y, Zhang Y, Lu J, et al
    The characteristics of and responses to the two COVID-19 outbreak waves in Hebei Province of China, January 2020 to February 2021.
    Epidemiol Infect. 2021;149:e212.
    PubMed     Abstract available

  103. AKTAS YILDIRIM S, Sarikaya ZT, Ulugol H, Ozata S, et al
    Are surgical and non-operating room intervention safe in the COVID-19 pandemic? A retrospective study.
    Epidemiol Infect. 2021;149:e210.
    PubMed     Abstract available

  104. GOLDENFELD M, Zuckerman N, Amit S, Tal I, et al
    First reported nosocomial SARS-CoV-2 outbreak in a hospital-based laundry facility.
    Epidemiol Infect. 2021;150:e18.
    PubMed     Abstract available

  105. MUSA OAH, Chivese T, Bansal D, Abdulmajeed J, et al
    Prevalence and determinants of symptomatic COVID-19 infection among children and adolescents in Qatar: a cross-sectional analysis of 11 445 individuals.
    Epidemiol Infect. 2021;149:e203.

  106. SPINICCI M, Pengue L, Bartolozzi D, Quercioli M, et al
    Soccer in the time of COVID-19: 1 year report from an Italian top league club, March 2020-February 2021.
    Epidemiol Infect. 2021;149:e207.
    PubMed     Abstract available

  107. IMPOUMA B, Williams GS, Moussana F, Mboussou F, et al
    The first 8 months of COVID-19 pandemic in three West African countries: leveraging lessons learned from responses to the 2014-2016 Ebola virus disease outbreak.
    Epidemiol Infect. 2021;149:e258.
    PubMed     Abstract available

    August 2021
  108. ABU JABAL K, Ben-Amram H, Beiruti K, Brimat I, et al
    SARS-CoV-2 immunogenicity in individuals infected before and after COVID-19 vaccination: Israel, January-March 2021.
    Epidemiol Infect. 2021;149:e239.
    PubMed     Abstract available

  109. MBOUSSOU F, Impouma B, Farham B, Wolfe CM, et al
    Analysing the reported incidence of COVID-19 and factors associated in the World Health Organization African region as of 31 December 2020.
    Epidemiol Infect. 2021;149:e256.
    PubMed     Abstract available

  110. ALPCAN A, Tursun S, Kandur Y
    Vitamin D levels in children with COVID-19: a report from Turkey.
    Epidemiol Infect. 2021;149:e180.
    PubMed     Abstract available

  111. NAESENS R, Mertes H, Clukers J, Herzog S, et al
    SARS-CoV-2 seroprevalence survey among health care providers in a Belgian public multiple-site hospital.
    Epidemiol Infect. 2021;149:e172.
    PubMed     Abstract available

  112. BAUMEISTER A, Corrin T, Abid H, Young KM, et al
    The quality of systematic reviews and other synthesis in the time of COVID-19.
    Epidemiol Infect. 2021;149:e182.
    PubMed     Abstract available

  113. CHENG CH, Chow CL, Chow WK
    A discussion on the minimum required number of tests in two common pooling test methods for SARS-CoV-2.
    Epidemiol Infect. 2021;149:e179.
    PubMed     Abstract available

  114. MELOTTI R, Scaggiante F, Falciani M, Weichenberger CX, et al
    Prevalence and determinants of serum antibodies to SARS-CoV-2 in the general population of the Gardena valley.
    Epidemiol Infect. 2021;149:e194.
    PubMed     Abstract available

  115. KELLY G, Petti S, Noah N
    Covid-19, non-Covid-19 and excess mortality rates not comparable across countries.
    Epidemiol Infect. 2021;149:e176.
    PubMed     Abstract available

  116. ALVES JD, Abade AS, Peres WP, Borges JE, et al
    Impact of COVID-19 on the indigenous population of Brazil: a geo-epidemiological study.
    Epidemiol Infect. 2021;149:e185.
    PubMed     Abstract available

    July 2021
  117. OTTAVIANO E, Parodi C, Borghi E, Massa V, et al
    Saliva detection of SARS-CoV-2 for mitigating company outbreaks: a surveillance experience, Milan, Italy, March 2021.
    Epidemiol Infect. 2021;149:e171.
    PubMed     Abstract available

  118. YI B, Poetsch AR, Stadtmuller M, Rost F, et al
    Phylogenetic analysis of SARS-CoV-2 lineage development across the first and second waves in Eastern Germany in 2020: insights into the cause of the second wave.
    Epidemiol Infect. 2021;149:e177.
    PubMed     Abstract available

  119. CARLTON LH, Chen T, Whitcombe AL, McGregor R, et al
    Charting elimination in the pandemic: a SARS-CoV-2 serosurvey of blood donors in New Zealand.
    Epidemiol Infect. 2021;149:e173.
    PubMed     Abstract available

  120. YAMADA G, Hayakawa K, Matsunaga N, Terada M, et al
    Predicting respiratory failure for COVID-19 patients in Japan: a simple clinical score for evaluating the need for hospitalisation.
    Epidemiol Infect. 2021;149:e175.
    PubMed     Abstract available

  121. BREWER TF, Zhang M, Gordon D, Chung RY, et al
    Housing, sanitation and living conditions affecting SARS-CoV-2 prevention interventions in 54 African countries.
    Epidemiol Infect. 2021;149:e183.
    PubMed     Abstract available

  122. YAKOB L
    Isolation thresholds for curbing SARS-CoV-2 resurgence.
    Epidemiol Infect. 2021;149:e168.
    PubMed     Abstract available

  123. THOMAS BS, Marks NA
    Estimating the case fatality ratio for COVID-19 using a time-shifted distribution analysis.
    Epidemiol Infect. 2021;149:e197.
    PubMed     Abstract available

  124. BOENDER TS, Bender JK, Kruger A, Michaelis K, et al
    Factors preventing SARS-CoV-2 transmission during unintentional exposure in a GP practice: a cohort study of patient contacts; Germany, 2020.
    Epidemiol Infect. 2021;149:e161.
    PubMed     Abstract available

    Estimation of delay-adjusted all-cause excess mortality in the USA: March-December 2020.
    Epidemiol Infect. 2021;149:e156.
    PubMed     Abstract available

  126. DITE GS, Murphy NM, Allman R
    Development and validation of a clinical and genetic model for predicting risk of severe COVID-19.
    Epidemiol Infect. 2021;149:e162.
    PubMed     Abstract available

  127. MUSA OAH, Chivese T, Bansal D, Abdulmajeed J, et al
    Prevalence and determinants of symptomatic COVID-19 infection among children and adolescents in Qatar: a cross-sectional analysis of 11 445 individuals.
    Epidemiol Infect. 2021;149:e193.
    PubMed     Abstract available

    June 2021
    RE: George et al. 'High seroprevalence of COVID-19 infection in a large slum in South India; what does it tell us about managing a pandemic and beyond?'
    Epidemiol Infect. 2021;149:e151.

  129. GEORGE CE, Inbaraj LR
    Re: George et al. High seroprevalence of COVID-19 infection in a large slum in South India; what does it tell us about managing a pandemic and beyond?
    Epidemiol Infect. 2021;149:e152.

  130. GOZLAN Y, Reingold S, Koren R, Halpern O, et al
    SARS-CoV-2 outbreak in a synagogue community: longevity and strength of anti-SARS-CoV-2 IgG responses.
    Epidemiol Infect. 2021;149:e153.
    PubMed     Abstract available

  131. WOUDENBERG T, Eberle U, Marosevic D, Liebl B, et al
    Detection and viral RNA shedding of SARS-CoV-2 in respiratory specimens relative to symptom onset among COVID-19 patients in Bavaria, Germany.
    Epidemiol Infect. 2021;149:e150.
    PubMed     Abstract available

  132. ZHANG R, Gao Y, Xie D, Lian R, et al
    Characteristics of systematic reviews evaluating treatments for COVID-19 registered in PROSPERO.
    Epidemiol Infect. 2021;149:e146.
    PubMed     Abstract available

  133. MALDONADO MD, Romero-Aibar J, Perez-San-Gregorio MA
    COVID-19 pandemic as a risk factor for the reactivation of herpes viruses.
    Epidemiol Infect. 2021;149:e145.
    PubMed     Abstract available

  134. DE MARCO VERISSIMO C, O'Brien C, Lopez Corrales J, Dorey A, et al
    Improved diagnosis of SARS-CoV-2 by using nucleoprotein and spike protein fragment 2 in quantitative dual ELISA tests.
    Epidemiol Infect. 2021;149:e140.
    PubMed     Abstract available

  135. GUVEN BB, Erturk T, Kompe O, Ersoy A, et al
    Serious complications in COVID-19 ARDS cases: pneumothorax, pneumomediastinum, subcutaneous emphysema and haemothorax.
    Epidemiol Infect. 2021;149:e137.
    PubMed     Abstract available

    May 2021
  136. IMPOUMA B, Mlanda T, Bukhari A, Sie Williams G, et al
    Information management practices in the WHO African Region to support response to the COVID-19 pandemic.
    Epidemiol Infect. 2021;149:e260.
    PubMed     Abstract available

  137. JAIN J, Saurabh S, Kumar P, Verma MK, et al
    COVID-19 vaccine hesitancy among medical students in India.
    Epidemiol Infect. 2021;149:e132.
    PubMed     Abstract available

  138. MCDONALD SA, van den Wijngaard CC, Wielders CCH, Friesema IHM, et al
    Risk factors associated with the incidence of self-reported COVID-19-like illness: data from a web-based syndromic surveillance system in the Netherlands.
    Epidemiol Infect. 2021;149:e129.
    PubMed     Abstract available

  139. DE SOUZA ARAUJO AA, Quintans-Junior LJ, Heimfarth L, Schimieguel DM, et al
    Seroprevalence of SARS-CoV-2 antibodies in the poorest region of Brazil: results from a population-based study.
    Epidemiol Infect. 2021;149:e130.
    PubMed     Abstract available

  140. HAMMER CC, Cristea V, Dub T, Sivela J, et al
    High but slightly declining COVID-19 vaccine acceptance and reasons for vaccine acceptance, Finland April to December 2020.
    Epidemiol Infect. 2021;149:e123.
    PubMed     Abstract available

  141. IMPOUMA B, Mboussou F, Wolfe CM, Farham B, et al
    COVID-19 in the WHO African region: using risk assessment to inform decisions on public health and social measures.
    Epidemiol Infect. 2021;149:e259.
    PubMed     Abstract available

    April 2021
  142. MAJUMDAR P, Niyogi S
    SARS-CoV-2 mutations: the biological trackway towards viral fitness.
    Epidemiol Infect. 2021;149:e110.
    PubMed     Abstract available

  143. CRUZ EHM, Maciel JM, Clozato CL, Serpa MS, et al
    Simulation-based evaluation of school reopening strategies during COVID-19: A case study of Sao Paulo, Brazil.
    Epidemiol Infect. 2021;149:e118.
    PubMed     Abstract available

  144. ZHAO S, Yang Z, Musa SS, Ran J, et al
    Attach importance of the bootstrap t test against Student's t test in clinical epidemiology: a demonstrative comparison using COVID-19 as an example.
    Epidemiol Infect. 2021;149:e107.
    PubMed     Abstract available

  145. VERA-ZERTUCHE JM, Mancilla-Galindo J, Tlalpa-Prisco M, Aguilar-Alonso P, et al
    Obesity is a strong risk factor for short-term mortality and adverse outcomes in Mexican patients with COVID-19: a national observational study.
    Epidemiol Infect. 2021;149:e109.
    PubMed     Abstract available

  146. MOUSSA R, Majdalani S
    Use of the Hayami diffusive wave equation to model the relationship infected-recoveries-deaths of Covid-19 pandemic.
    Epidemiol Infect. 2021;149:e138.
    PubMed     Abstract available

  147. SHARIF N, Ahmed SN, Opu RR, Daullah MU, et al
    Impact of meteorological parameters and population density on variants of SARS-CoV-2 and outcome of COVID-19 pandemic in Japan.
    Epidemiol Infect. 2021;149:e103.
    PubMed     Abstract available

  148. KIM SH, Kim YJ, Jeong YJ, Park JH, et al
    Construction of a non-contact community treatment centre for asymptomatic and mildly symptomatic COVID-19 patients during the COVID-19 pandemic.
    Epidemiol Infect. 2021;149:e111.
    PubMed     Abstract available

  149. LOPEZ-CHEDA A, Jacome MA, Cao R, De Salazar PM, et al
    Estimating lengths-of-stay of hospitalised COVID-19 patients using a non-parametric model: a case study in Galicia (Spain).
    Epidemiol Infect. 2021;149:e102.
    PubMed     Abstract available

  150. KSHATRI JS, Bhattacharya D, Praharaj I, Mansingh A, et al
    Seroprevalence of SARS-CoV-2 in Bhubaneswar, India: findings from three rounds of community surveys.
    Epidemiol Infect. 2021;149:e139.
    PubMed     Abstract available

  151. ALLEN N, Riain UN, Conlon N, Ferenczi A, et al
    Prevalence of antibodies to SARS-CoV-2 in Irish hospital healthcare workers.
    Epidemiol Infect. 2021;149:e157.
    PubMed     Abstract available

  152. DRESSLER A, Finci I, Wagner-Wiening C, Eichner M, et al
    Epidemiological analysis of 3,219 COVID-19 outbreaks in the state of Baden-Wuerttemberg, Germany.
    Epidemiol Infect. 2021;149:e101.
    PubMed     Abstract available

  153. BAGGIO JAO, Machado MF, Carmo RFD, Armstrong ADC, et al
    COVID-19 in Brazil: spatial risk, social vulnerability, human development, clinical manifestations and predictors of mortality - a retrospective study with data from 59 695 individuals.
    Epidemiol Infect. 2021;149:e100.
    PubMed     Abstract available

  154. LUO S, Xin M, Wang S, Zhao J, et al
    Behavioural intention of receiving COVID-19 vaccination, social media exposures and peer discussions in China.
    Epidemiol Infect. 2021;149:e158.
    PubMed     Abstract available

  155. ZARE F, Teimouri M, Khosravi A, Rohani-Rasaf M, et al
    COVID-19 re-infection in Shahroud, Iran: a follow-up study.
    Epidemiol Infect. 2021;149:e159.
    PubMed     Abstract available

  156. MARCO A, Gallego C, Perez-Caceres V, Guerrero RA, et al
    Public health response to an outbreak of SARS-CoV2 infection in a Barcelona prison.
    Epidemiol Infect. 2021;149:e91.
    PubMed     Abstract available

  157. KARIMZADEH S, Bhopal R, Nguyen Tien H
    Review of infective dose, routes of transmission and outcome of COVID-19 caused by the SARS-COV-2: comparison with other respiratory viruses.
    Epidemiol Infect. 2021;149:e96.
    PubMed     Abstract available

  158. IMPOUMA B, Wolfe CM, Mboussou F, Farham B, et al
    Monitoring and evaluation of COVID-19 response in the WHO African region: challenges and lessons learned.
    Epidemiol Infect. 2021;149:e98.
    PubMed     Abstract available

  159. HU HY, Yan F, Zhu JM, Karuno AP, et al
    Intercontinental transmission and local demographic expansion of SARS-CoV-2.
    Epidemiol Infect. 2021;149:e94.
    PubMed     Abstract available

  160. MOETI M
    Leadership, collaboration and using data science to fight COVID-19 in the WHO African region.
    Epidemiol Infect. 2021;149:e262.

  161. SEMENZA JC, Adlhoch C, Baka A, Broberg E, et al
    COVID-19 research priorities for non-pharmaceutical public health and social measures.
    Epidemiol Infect. 2021;149:e87.
    PubMed     Abstract available

  162. MASSAD E, Amaku M, Tadeu Covas D, Fernandes Lopez L, et al
    Estimating the effects of reopening of schools on the course of the epidemic of COVID-19.
    Epidemiol Infect. 2021;149:e86.
    PubMed     Abstract available

  163. MAO Y, Tan YR, Thein TL, Chai YAL, et al
    Identifying COVID-19 cases in outpatient settings.
    Epidemiol Infect. 2021;149:e92.
    PubMed     Abstract available

    March 2021
  164. WANG K, Wang X, Du J, Liu C, et al
    Relationship between changes in the course of COVID-19 and ratio of neutrophils-to-lymphocytes and related parameters in patients with severe vs. common disease.
    Epidemiol Infect. 2021;149:e81.
    PubMed     Abstract available

  165. MUKHERJEE A, Anand T, Agarwal A, Singh H, et al
    SARS-CoV-2 re-infection: development of an epidemiological definition from India.
    Epidemiol Infect. 2021;149:e82.
    PubMed     Abstract available

  166. BLANCO N, Stafford KA, Lavoie MC, Brandenburg A, et al
    A simple model for the total number of SARS-CoV-2 infections on a national level.
    Epidemiol Infect. 2021;149:e80.
    PubMed     Abstract available

  167. GALLO O, Peris A, Trotta M, Orlando P, et al
    Epidemiological analysis of a COVID-19 outbreak associated with an infected surgeon.
    Epidemiol Infect. 2021;149:e77.
    PubMed     Abstract available

  168. OGIMI C, Qu P, Boeckh M, Bender Ignacio RA, et al
    Association between live childhood vaccines and COVID-19 outcomes: a national-level analysis.
    Epidemiol Infect. 2021;149:e75.
    PubMed     Abstract available

  169. KUCHENHOFF H, Gunther F, Hohle M, Bender A, et al
    Analysis of the early COVID-19 epidemic curve in Germany by regression models with change points.
    Epidemiol Infect. 2021;149:e68.
    PubMed     Abstract available

  170. KOZER E, Rinott E, Kozer G, Bar-Haim A, et al
    Presence of SARS-CoV-2 RNA on playground surfaces and water fountains.
    Epidemiol Infect. 2021;149:e67.
    PubMed     Abstract available

  171. ELSON R, Davies TM, Lake IR, Vivancos R, et al
    The spatio-temporal distribution of COVID-19 infection in England between January and June 2020.
    Epidemiol Infect. 2021;149:e73.
    PubMed     Abstract available

    Fourier analysis using the number of COVID-19 daily deaths in the US.
    Epidemiol Infect. 2021;149:e64.
    PubMed     Abstract available

  173. BOHM S, Woudenberg T, Chen D, Marosevic DV, et al
    Epidemiology and transmission characteristics of early COVID-19 cases, 20 January-19 March 2020, in Bavaria, Germany.
    Epidemiol Infect. 2021;149:e65.
    PubMed     Abstract available

    February 2021
  174. CASTRO RR, Santos RSC, Sousa GJB, Pinheiro YT, et al
    Spatial dynamics of the COVID-19 pandemic in Brazil.
    Epidemiol Infect. 2021;149:e60.
    PubMed     Abstract available

  175. MICHOS A, Savvidou P, Syridou G, Eleftheriou E, et al
    SARS-CoV-2 molecular testing in Greek hospital paediatric departments: a nationwide study.
    Epidemiol Infect. 2021;149:e70.
    PubMed     Abstract available

  176. CHENG A, Chen Y, Gao Y, Sun P, et al
    Mobile isolation wards in a fever clinic: a novel operation model during the COVID-19 pandemic.
    Epidemiol Infect. 2021;149:e61.
    PubMed     Abstract available

  177. HONG K, Yum SJ, Kim JH, Chun BC, et al
    Re-estimation of basic reproduction number of COVID-19 based on the epidemic curve by symptom onset date.
    Epidemiol Infect. 2021;149:e53.
    PubMed     Abstract available

  178. DUQUE MP, Lucaccioni H, Costa C, Marques R, et al
    COVID-19 symptoms: a case-control study, Portugal, March-April 2020.
    Epidemiol Infect. 2021;149:e54.
    PubMed     Abstract available

  179. LEHMANN J, Giesinger JM, Rumpold G, Borena W, et al
    Estimating seroprevalence of SARS-CoV-2 antibodies using three self-reported symptoms: development of a prediction model based on data from Ischgl, Austria.
    Epidemiol Infect. 2021;149:e52.
    PubMed     Abstract available

  180. ZHAO K, Ai L, Zhao Y, Wang T, et al
    Diagnostic value of using a combination of nucleic acid and specific antibody tests for SARS-CoV-2 in coronavirus disease 2019.
    Epidemiol Infect. 2021;149:e62.
    PubMed     Abstract available

  181. LELIS DA SILVA F, Dias Pita J, Gomes MDA, Lelis da Silva AP, et al
    Intraregional propagation of Covid-19 cases in Para, Brazil: assessment of isolation regime to lockdown.
    Epidemiol Infect. 2021;149:e72.
    PubMed     Abstract available

  182. GAO Y, Chen Y, Liu M, Niu M, et al
    Nervous system diseases are associated with the severity and mortality of patients with COVID-19: a systematic review and meta-analysis.
    Epidemiol Infect. 2021;149:e66.
    PubMed     Abstract available

  183. MIYAMA T, Iritani N, Nishio T, Ukai T, et al
    Seasonal shift in epidemics of respiratory syncytial virus infection in Japan.
    Epidemiol Infect. 2021;149:e55.
    PubMed     Abstract available

  184. AI J, Shi N, Shi Y, Xu K, et al
    Epidemiologic characteristics and influencing factors of cluster infection of COVID-19 in Jiangsu Province.
    Epidemiol Infect. 2021;149:e48.
    PubMed     Abstract available

  185. SHANG C, Yang Y, Chen GY, Shang XD, et al
    A simple transmission dynamics model for predicting the evolution of COVID-19 under control measures in China.
    Epidemiol Infect. 2021;149:e43.
    PubMed     Abstract available

  186. BAILIE CR, Franklin L, Nicholson S, Mordant F, et al
    Symptoms and laboratory manifestations of mild COVID-19 in a repatriated cruise ship cohort.
    Epidemiol Infect. 2021;149:e44.
    PubMed     Abstract available

  187. WEIBELZAHL S, Reiter J, Duden G
    Depression and anxiety in healthcare professionals during the COVID-19 pandemic.
    Epidemiol Infect. 2021;149:e46.
    PubMed     Abstract available

  188. GEORGE CE, Inbaraj LR, Chandrasingh S, de Witte LP, et al
    High seroprevalence of COVID-19 infection in a large slum in South India; what does it tell us about managing a pandemic and beyond?
    Epidemiol Infect. 2021;149:e39.
    PubMed     Abstract available

  189. KAMAR A, Maalouf N, Hitti E, El Eid G, et al
    Challenge of forecasting demand of medical resources and supplies during a pandemic: A comparative evaluation of three surge calculators for COVID-19.
    Epidemiol Infect. 2021;149:e51.
    PubMed     Abstract available

  190. SINGH RKS, Malik MZ, Singh RKB
    Diversity of SARS-CoV-2 isolates driven by pressure and health index.
    Epidemiol Infect. 2021;149:e38.
    PubMed     Abstract available

    January 2021
  191. PETT J, McAleavey P, McGurnaghan P, Spiers R, et al
    Epidemiology of COVID-19 in Northern Ireland, 26 February 2020-26 April 2020.
    Epidemiol Infect. 2021;149:e36.
    PubMed     Abstract available

  192. PRANATA R, Lim MA, Yonas E, Huang I, et al
    Thrombocytopenia as a prognostic marker in COVID-19 patients: diagnostic test accuracy meta-analysis.
    Epidemiol Infect. 2021;149:e40.
    PubMed     Abstract available

    Urgent need for evaluation of point-of-care tests as an RT-PCR-sparing strategy for the diagnosis of Covid-19 in symptomatic patients.
    Epidemiol Infect. 2021;149:e35.

  194. CHOW WK, Chow CL
    Response to Letter to Editor by Zavascki A.P.: Urgent need for evaluating point-of-care tests as a RT-PCR-sparing strategy for the diagnosis of Covid-19 in symptomatic patients.
    Epidemiol Infect. 2021;149:e33.

  195. WANG Y, Luo H, Liu S, Hao T, et al
    Respiratory failure among patients with COVID-19 in Jiangsu province, China: a multicentre retrospective cohort study.
    Epidemiol Infect. 2021;149:e31.
    PubMed     Abstract available

  196. SETHI SM, Ahmed AS, Hanif S, Aqeel M, et al
    Subcutaneous emphysema and pneumomediastinum in patients with COVID-19 disease; case series from a tertiary care hospital in Pakistan.
    Epidemiol Infect. 2021;149:e37.
    PubMed     Abstract available

  197. VENTURELLI S, Benatti SV, Casati M, Binda F, et al
    Surviving COVID-19 in Bergamo province: a post-acute outpatient re-evaluation.
    Epidemiol Infect. 2021;149:e32.
    PubMed     Abstract available

  198. WENG CH, Saal A, McGuire DC, Chan PA, et al
    Persistently high SARS-CoV-2 positivity rate and incidence for Hispanic/Latinos during state reopening in an urban setting: a retrospective cohort study.
    Epidemiol Infect. 2021;149:e25.
    PubMed     Abstract available

  199. LE TD, Bosworth M, Ledlow G, Le TT, et al
    Influences of reopening businesses and social venues: COVID-19 incidence rate in East Texas county.
    Epidemiol Infect. 2021;149:e28.
    PubMed     Abstract available

  200. WEI J, Guo S, Long E, Zhang L, et al
    Why does the spread of COVID-19 vary greatly in different countries? Revealing the efficacy of face masks in epidemic prevention.
    Epidemiol Infect. 2021;149:e24.
    PubMed     Abstract available

  201. ISHIKAWA G, Argenti G, Fadel CB
    Non-specific blood tests as proxies for COVID-19 hospitalisation: are there plausible associations after excluding noisy predictors?
    Epidemiol Infect. 2021;149:e23.
    PubMed     Abstract available

  202. LI W, Gong J, Zhou J, Zhang L, et al
    An evaluation of COVID-19 transmission control in Wenzhou using a modified SEIR model.
    Epidemiol Infect. 2021;149:e2.
    PubMed     Abstract available

  203. GE Y, Sun S, Shen Y
    Estimation of case-fatality rate in COVID-19 patients with hypertension and diabetes mellitus in the New York state: a preliminary report.
    Epidemiol Infect. 2021;149:e14.
    PubMed     Abstract available

  204. SALMON RL, Monaghan SP
    Who is dying from COVID-19 in the United Kingdom? A review of cremation authorisations from a single South Wales' crematorium.
    Epidemiol Infect. 2021;149:e13.
    PubMed     Abstract available

  205. SHARIF N, Dey SK
    Impact of population density and weather on COVID-19 pandemic and SARS-CoV-2 mutation frequency in Bangladesh.
    Epidemiol Infect. 2021;149:e16.
    PubMed     Abstract available

  206. LIU Y, Haussinger L, Steinacker JM, Dinse-Lambracht A, et al
    Association between the dynamics of the COVID-19 epidemic and ABO blood type distribution.
    Epidemiol Infect. 2021;149:e19.
    PubMed     Abstract available

  207. ILESANMI OS, Afolabi AA, Akande A, Raji T, et al
    Infection prevention and control during COVID-19 pandemic: realities from health care workers in a north central state in Nigeria.
    Epidemiol Infect. 2021;149:e15.
    PubMed     Abstract available

  208. WEI ZY, Qiao R, Chen J, Huang J, et al
    The influence of pre-existing hypertension on coronavirus disease 2019 patients.
    Epidemiol Infect. 2021;149:e4.
    PubMed     Abstract available

  209. LIANG C, Shen L
    An analysis of coronavirus disease 2019 with spline regression at province level during first-level response to major public health emergency out of Hubei, China.
    Epidemiol Infect. 2021;149:e10.
    PubMed     Abstract available

  210. CHOW WK, Chow CL
    A discussion on implementing pooling detection tests of novel coronavirus (SARS-CoV-2) for a large population.
    Epidemiol Infect. 2021;149:e17.
    PubMed     Abstract available

  211. DENG L, Zhang J, Wang M, Chen L, et al
    Obesity is associated with severe COVID-19 but not death: a dose-response meta-analysis.
    Epidemiol Infect. 2021;149:e144.
    PubMed     Abstract available

    December 2020
  212. WEI C, Lee CC, Hsu TC, Hsu WT, et al
    Correlation of population mortality of COVID-19 and testing coverage: a comparison among 36 OECD countries.
    Epidemiol Infect. 2020;149:e1.
    PubMed     Abstract available

  213. FERNANDEZ-SALINAS J, Aragon-Caqueo D, Valdes G, Laroze D, et al
    Modelling pool testing for SARS-CoV-2: addressing heterogeneity in populations.
    Epidemiol Infect. 2020;149:e9.
    PubMed     Abstract available

  214. YANG J, Ma Z, Lei Y
    A meta-analysis of the association between obesity and COVID-19.
    Epidemiol Infect. 2020;149:e11.
    PubMed     Abstract available

  215. ARINO J, Bajeux N, Portet S, Watmough J, et al
    Quarantine and the risk of COVID-19 importation.
    Epidemiol Infect. 2020;148:e298.
    PubMed     Abstract available

  216. YUNG CF, Saffari E, Liew C
    Time to Rt < 1 for COVID-19 public health lockdown measures.
    Epidemiol Infect. 2020;148:e301.
    PubMed     Abstract available

  217. YOUNG BE, Mak TM, Ang LW, Sadarangani S, et al
    Influenza vaccine failure in the tropics: a retrospective cohort study of waning effectiveness.
    Epidemiol Infect. 2020 Dec 2:1-29. doi: 10.1017/S0950268820002952.

  218. DE ALMEIDA GB, Pronunciate M, Grotto RMT, Azevedo Pugliesi E, et al
    Two hundred days of COVID-19 in Sao Paulo State, Brazil.
    Epidemiol Infect. 2020;148:e295.
    PubMed     Abstract available

  219. ANDRADE LA, Gomes DS, Lima SVMA, Duque AM, et al
    COVID-19 mortality in an area of northeast Brazil: epidemiological characteristics and prospective spatiotemporal modelling.
    Epidemiol Infect. 2020;148:e288.
    PubMed     Abstract available

  220. MO P, Deng L, Liu X, Gao S, et al
    Risk factors for delayed negative conversion of SARS-CoV-2 in patients with COVID-19 pneumonia: a retrospective cohort study.
    Epidemiol Infect. 2020;148:e293.
    PubMed     Abstract available

    November 2020
  221. MANCILLA-GALINDO J, Vera-Zertuche JM, Navarro-Cruz AR, Segura-Badilla O, et al
    Development and validation of the patient history COVID-19 (PH-Covid19) scoring system: a multivariable prediction model of death in Mexican patients with COVID-19.
    Epidemiol Infect. 2020;148:e286.
    PubMed     Abstract available

  222. THOMPSON JV, Meghani NJ, Powell BM, Newell I, et al
    Patient characteristics and predictors of mortality in 470 adults admitted to a district general hospital in England with Covid-19.
    Epidemiol Infect. 2020;148:e285.
    PubMed     Abstract available

  223. CAO Y, Wang Y, Das A, Pan CQ, et al
    Transmission dynamics of COVID-19 among index case family clusters in Beijing, China.
    Epidemiol Infect. 2020;149:e74.
    PubMed     Abstract available

  224. HABONIMANA D, Ouedraogo L, Ndirahisha E, Misago N, et al
    Understanding the influence of the COVID-19 pandemic on hospital-based mortality in Burundi: a cross-sectional study comparing two time periods.
    Epidemiol Infect. 2020;148:e280.
    PubMed     Abstract available

  225. SANTAMARIA L, Hortal J
    Chasing the ghost of infection past: identifying thresholds of change during the COVID-19 infection in Spain.
    Epidemiol Infect. 2020;148:e282.
    PubMed     Abstract available

  226. SUNG J, Choudry N, Bachour R
    Development and validation of a simple risk score for diagnosing COVID-19 in the emergency room.
    Epidemiol Infect. 2020;148:e273.
    PubMed     Abstract available

  227. SULYOK M, Walker M
    Community movement and COVID-19: a global study using Google's Community Mobility Reports.
    Epidemiol Infect. 2020;148:e284.
    PubMed     Abstract available

  228. SHAKIBA M, Nazemipour M, Heidarzadeh A, Mansournia MA, et al
    Prevalence of asymptomatic COVID-19 infection using a seroepidemiological survey.
    Epidemiol Infect. 2020;148:e300.
    PubMed     Abstract available

  229. KAZANCIOGLU S, Bastug A, Ozbay BO, Kemirtlek N, et al
    The Role of Hematological Parameters in Patients with Coronavirus Disease 2019 and Influenza Virus Infection.
    Epidemiol Infect. 2020 Nov 5:1-16. doi: 10.1017/S095026882000271.

  230. GREBE G, Velez JA, Tiutiunnyk A, Aragon-Caqueo D, et al
    Dynamic quarantine: a comparative analysis of the Chilean public health response to COVID-19.
    Epidemiol Infect. 2020;148:e270.
    PubMed     Abstract available

  231. GURSAKAL N, Batmaz B, Aktuna G
    Drawing transmission graphs for COVID-19 in the perspective of network science.
    Epidemiol Infect. 2020;148:e269.
    PubMed     Abstract available

    October 2020
  232. ISLAM MZ, Riaz BK, Islam ANMS, Khanam F, et al
    Risk factors associated with morbidity and mortality outcomes of COVID-19 patients on the 28th day of the disease course: a retrospective cohort study in Bangladesh.
    Epidemiol Infect. 2020;148:e263.
    PubMed     Abstract available

  233. RIVERA R, Rosenbaum JE, Quispe W
    Excess mortality in the United States during the first three months of the COVID-19 pandemic.
    Epidemiol Infect. 2020;148:e264.
    PubMed     Abstract available

  234. MAJUMDAR P, Niyogi S
    ORF3a mutation associated with higher mortality rate in SARS-CoV-2 infection.
    Epidemiol Infect. 2020;148:e262.
    PubMed     Abstract available

  235. MEIKSIN A
    Dynamics of COVID-19 transmission including indirect transmission mechanisms: a mathematical analysis.
    Epidemiol Infect. 2020;148:e257.
    PubMed     Abstract available

  236. ZHANG SX, Graf-Vlachy L, Looi KH, Su R, et al
    Social media use as a predictor of handwashing during a pandemic: evidence from COVID-19 in Malaysia.
    Epidemiol Infect. 2020;148:e261.
    PubMed     Abstract available

  237. ZENG L, Wang S, Cai J, Sun S, et al
    Clinical characteristics of COVID-19 with cardiac injury: a systematic review and meta-analysis.
    Epidemiol Infect. 2020;148:e266.
    PubMed     Abstract available

  238. DE SALAZAR PM, Gomez-Barroso D, Pampaka D, Gil JM, et al
    Lockdown measures and relative changes in the age-specific incidence of SARS-CoV-2 in Spain.
    Epidemiol Infect. 2020;148:e268.
    PubMed     Abstract available

  239. LI X, Marmar T, Xu Q, Tu J, et al
    Predictive indicators of severe COVID-19 independent of comorbidities and advanced age: a nested case-control study.
    Epidemiol Infect. 2020;148:e255.
    PubMed     Abstract available

  240. BRANDL M, Selb R, Seidl-Pillmeier S, Marosevic D, et al
    Mass gathering events and undetected transmission of SARS-CoV-2 in vulnerable populations leading to an outbreak with high case fatality ratio in the district of Tirschenreuth, Germany.
    Epidemiol Infect. 2020;148:e252.
    PubMed     Abstract available

  241. TEIXEIRA R, Doetsch J
    The multifaceted role of mobile technologies as a strategy to combat COVID-19 pandemic.
    Epidemiol Infect. 2020;148:e244.
    PubMed     Abstract available

  242. TAKAYA S, Tsuzuki S, Hayakawa K, Kawashima A, et al
    Nightlife clusters of coronavirus disease in Tokyo between March and April 2020.
    Epidemiol Infect. 2020;148:e250.
    PubMed     Abstract available

  243. GOODALL JW, Reed TAN, Ardissino M, Bassett P, et al
    Risk factors for severe disease in patients admitted with COVID-19 to a hospital in London, England: a retrospective cohort study.
    Epidemiol Infect. 2020;148:e251.
    PubMed     Abstract available

  244. KHAN ZS, Van Bussel F, Hussain F
    A predictive model for Covid-19 spread - with application to eight US states and how to end the pandemic.
    Epidemiol Infect. 2020;148:e249.
    PubMed     Abstract available

  245. SIFF EJ, Aghagoli G, Gallo Marin B, Tobin-Tyler E, et al
    SARS-CoV-2 transmission: a sociological review.
    Epidemiol Infect. 2020;148:e242.
    PubMed     Abstract available

  246. WANG Y, Xu C, Yao S, Zhao Y, et al
    Forecasting the epidemiological trends of COVID-19 prevalence and mortality using the advanced alpha-Sutte Indicator.
    Epidemiol Infect. 2020;148:e236.
    PubMed     Abstract available

  247. GUO J, Zhou B, Zhu M, Yuan Y, et al
    CURB-65 may serve as a useful prognostic marker in COVID-19 patients within Wuhan, China: a retrospective cohort study.
    Epidemiol Infect. 2020;148:e241.
    PubMed     Abstract available

    September 2020
  248. SHI P, Ren G, Yang J, Li Z, et al
    Clinical characteristics of imported and second-generation coronavirus disease 2019 (COVID-19) cases in Shaanxi outside Wuhan, China: a multicentre retrospective study.
    Epidemiol Infect. 2020;148:e238.
    PubMed     Abstract available

  249. SINGH D, Joshi K, Samuel A, Patra J, et al
    Alcohol-based hand sanitisers as first line of defence against SARS-CoV-2: a review of biology, chemistry and formulations.
    Epidemiol Infect. 2020;148:e229.
    PubMed     Abstract available

  250. LOPEZ-ABENTE J, Valor-Suarez C, Lopez-Abente G
    Massive application of the SARS-CoV-2 diagnostic test: simulation of its effect on the evolution of the epidemic in Spain.
    Epidemiol Infect. 2020;148:e233.
    PubMed     Abstract available

  251. FERNANDES DE, Ferreira PRA, Mastroianni Kirsztajn G
    Pre-exposure prophylaxis during the SARS-CoV-2 pandemic: can PrEP prevent COVID-19-related symptoms?
    Epidemiol Infect. 2020;148:e231.
    PubMed     Abstract available

  252. GUBENSEK J, Vajdic Trampuz B, Persic V, Gregorcic S, et al
    The possibility of SARS-CoV-2 transmission in a haemodialysis unit - report from a large in-hospital centre.
    Epidemiol Infect. 2020;148:e226.
    PubMed     Abstract available

  253. SARASWATHI S, Mukhopadhyay A, Shah H, Ranganath TS, et al
    Social network analysis of COVID-19 transmission in Karnataka, India.
    Epidemiol Infect. 2020;148:e230.
    PubMed     Abstract available

  254. ZONGO P, Zorom M, Mophou G, Dorville R, et al
    A model of COVID-19 transmission to understand the effectiveness of the containment measures: application to data from France.
    Epidemiol Infect. 2020;148:e221.
    PubMed     Abstract available

  255. CHEEMA S, Ameduri M, Abraham A, Doraiswamy S, et al
    The COVID-19 pandemic: the public health reality.
    Epidemiol Infect. 2020;148:e223.
    PubMed     Abstract available

  256. CHEN M, Wei X, Wang Z
    Protecting healthcare workers from SARS-CoV-2 and other infections.
    Epidemiol Infect. 2020;148:e217.
    PubMed     Abstract available

  257. AHMAD I, Muhammad Asad S
    Predictions of coronavirus COVID-19 distinct cases in Pakistan through an artificial neural network.
    Epidemiol Infect. 2020;148:e222.
    PubMed     Abstract available

  258. CHEN LZ, Lin ZH, Chen J, Liu SS, et al
    Can elevated concentrations of ALT and AST predict the risk of 'recurrence' of COVID-19?
    Epidemiol Infect. 2020;148:e218.
    PubMed     Abstract available

  259. SONG W, Sawafta FJ, Ebrahem BM, Jebril MA, et al
    Public attitude towards quarantine during the COVID-19 outbreak.
    Epidemiol Infect. 2020;148:e220.
    PubMed     Abstract available

  260. DUAN P, Deng ZQ, Pan ZY, Wang YP, et al
    Safety considerations during return to work in the context of stable COVID-19 epidemic control: an analysis of health screening results of all returned staff from a hospital.
    Epidemiol Infect. 2020;148:e214.
    PubMed     Abstract available

  261. HAW NJL, Uy J, Sy KTL, Abrigo MRM, et al
    Epidemiological profile and transmission dynamics of COVID-19 in the Philippines.
    Epidemiol Infect. 2020;148:e204.
    PubMed     Abstract available

  262. TINTO B, Salinas S, Dicko A, Kagone TS, et al
    Spreading of SARS-CoV-2 in West Africa and assessment of risk factors.
    Epidemiol Infect. 2020;148:e213.
    PubMed     Abstract available

  263. ELIMIAN KO, Ochu CL, Ilori E, Oladejo J, et al
    Descriptive epidemiology of coronavirus disease 2019 in Nigeria, 27 February-6 June 2020.
    Epidemiol Infect. 2020;148:e208.
    PubMed     Abstract available

  264. BISWAS RK, Afiaz A, Huq S
    Underreporting COVID-19: the curious case of the Indian subcontinent.
    Epidemiol Infect. 2020;148:e207.
    PubMed     Abstract available

  265. WANG X, Li X, Shang Y, Wang J, et al
    Ratios of neutrophil-to-lymphocyte and platelet-to-lymphocyte predict all-cause mortality in inpatients with coronavirus disease 2019 (COVID-19): a retrospective cohort study in a single medical centre.
    Epidemiol Infect. 2020;148:e211.
    PubMed     Abstract available

  266. HAIDER N, Yavlinsky A, Chang YM, Hasan MN, et al
    The Global Health Security index and Joint External Evaluation score for health preparedness are not correlated with countries' COVID-19 detection response time and mortality outcome.
    Epidemiol Infect. 2020;148:e210.
    PubMed     Abstract available

  267. GAYAWAN E, Awe OO, Oseni BM, Uzochukwu IC, et al
    The spatio-temporal epidemic dynamics of COVID-19 outbreak in Africa.
    Epidemiol Infect. 2020;148:e212.
    PubMed     Abstract available

    August 2020
  268. LAI R, Chen E, Gao W, Cheng C, et al
    Sentinel surveillance strategies for early detection of coronavirus disease in fever clinics: experience from China.
    Epidemiol Infect. 2020;148:e205.
    PubMed     Abstract available

  269. LANARI M, Anderson EJ, Sheridan-Pereira M, Carbonell-Estrany X, et al
    Burden of respiratory syncytial virus hospitalisation among infants born at 32-35 weeks' gestational age in the Northern Hemisphere: pooled analysis of seven studies.
    Epidemiol Infect. 2020;148:e170.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.